Prostate cancer Board decisions

The Veteran is granted service connection for residuals of prostate cancer and tinnitus, both presumed to be related to herbicide exposure in Vietnam.

The Board denied the Veteran's claim for an earlier effective date for service connection of prostate cancer, finding that no earlier effective date could be assigned due to lack of evidence showing a claim was filed prior to October 6, 2008.

The Veteran's appeal has been withdrawn prior to the Board making a decision.

The Board finds that the Veteran does not have a current diagnosis of a bilateral ankle disorder or prostate cancer, and there is no evidence linking these conditions to his military service. The claim for service connection for a bilateral ankle disorder is denied as secondary to service-connected bilateral pes planus is also denied.

The Veteran's prostate cancer residuals are rated at 60 percent disabling, effective the date of this decision.

The Veteran is seeking service connection for prostate cancer and erectile dysfunction, which he claims are due to exposure to Agent Orange in Vietnam. The case has been remanded to obtain additional information regarding the transfer flight from the Philippines to the United States.

The Veteran's postoperative residuals of prostate cancer warrant a 100 percent rating from the date of award of service connection until, at least, August 14, 2008.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that it was not incurred in or aggravated by his military service and did not have a link to Agent Orange exposure.

The Veteran's death was caused by coronary artery disease, which is presumed to be due to exposure to herbicide agents in service. The claim for DIC benefits under 38 U.S.C.A. § 1318 is moot as the cause of death claim has been granted.

The Board is remanding the case to obtain a medical opinion regarding whether any service-connected disabilities contributed to the Veteran's death, and to ensure that all relevant evidence has been considered in making this determination.

The Veteran's death was due to metastatic prostate cancer, which is service-connected. Therefore, the claim for DIC benefits based on the cause of death is granted.

The Veteran's prostate cancer is presumed to have been incurred in service due to his Vietnam-era service, and he is granted service connection for this condition.

The Board is remanding the case to obtain SSA disability records and for further consideration of the claim.

The Veteran's erectile dysfunction, as secondary to his service-connected prostate cancer, is not shown to be associated with a penile deformity. Therefore, he does not meet the criteria for a compensable disability rating under Diagnostic Code 7522.

The Veteran's prostate cancer residuals are rated at a 40 percent rating, which is higher than the initially assigned 20 percent rating. The Veteran argued for this increase based on his current symptoms of frequent urination.

The Veteran's prostate cancer has been rated at 100 percent since July 2004. The VA examiner found that the Veteran no longer requires an appliance or absorbent materials due to his low PSA levels and mild urinary symptoms, resulting in a reduced rating from 100% to 60%. The Veteran's prostate cancer is not currently active.

The Board has determined that the Veteran's prostate cancer is a result of VA medical treatment rendered between 1995 and 2005, which included failure to conduct yearly PSA screenings. The claim for compensation under 38 U.S.C.A. § 1151 is granted.

The Veteran's prostate cancer is service-connected as it is presumptively associated with Agent Orange exposure during his service in Korea.

The Board has remanded the case due to outstanding VA and private treatment records, as well as a need for further examination regarding the Veteran's HIV.